# Bioequivalence (BE) Study Between YHP2511 and YHP2511A in Healthy Volunteers

> **NCT07470125** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Yuhan Corporation** · enrollment: 60 (estimated)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** YHP2511
- **DRUG:** YHP2511A

## Key facts

- **NCT ID:** NCT07470125
- **Lead sponsor:** Yuhan Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-23
- **Primary completion:** 2026-07-11
- **Final completion:** 2026-07-11
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07470125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07470125, "Bioequivalence (BE) Study Between YHP2511 and YHP2511A in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07470125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*